Acta Neuropathologica

, Volume 78, Issue 2, pp 189–193 | Cite as

The mononuclear cell infiltrate compared with survival in high-grade astrocytomas

  • M. I. Rossi
  • N. R. Jones
  • E. Candy
  • J. A. R. Nicoll
  • J. S. Compton
  • J. T. Hughes
  • M. M. Esiri
  • T. H. Moss
  • F. F. Cruz-Sanchez
  • H. B. Coakham
Regular Papers

Summary

Frozen samples from 92 malignant astrocytomas were stained with a panel of monoclonal antibodies directed against macrophages and lymphocytes. A follow-up to death was available on 68 cases which form the basis of this study. Large numbers of macrophages were found in all cases; T lymphocytes, mostly of the CD8 phenotype were also seen in moderate numbers in 70% of cases. CD4-positive cells were present in small numbers in 32% and B cells were seen in only 8% of cases. Analysis of the survival showed no demonstrable correlation between the numbers of macrophages or CD4 lymphocytes and survival. The survival curves for parencymal CD8 infiltration diverged after 9 months suggesting increased survival for those patients without such an infiltration but the difference failed to reach statistical significance (P=0.37). No correlation between lymphocytic cuffing and survival was seen after studying all paraffinembedded material. We conclude that there is no significant statistical correlation between survival and the various types of mononuclear cell infiltrating malignant astrocytomas.

Key words

Astrocytoma Macrophage Lymphocyte Mononuclear cells Survival 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alexander P (1967) Cellular resistance to tumours. Br Med Bull 23:86–92Google Scholar
  2. 2.
    Alexander P (1976) The functions of the macrophages in malignant disease. Annu Rev Med 27:207–224Google Scholar
  3. 3.
    Apuzzo MLJ, Mitchell MS (1981) Immunological aspects of intrinsic glial tumours. J Neurosurg 55:1–18Google Scholar
  4. 4.
    Bertrand I, Mannen H (1960) Etudes des reactions vasculaires dans les astrocytomes. Rev Neurol (Paris) 102:3–19Google Scholar
  5. 5.
    Brooks WH, Roszman TL, Rogers AS (1976) Impairment of rosette-forming T lymphocytes in patients with primary intracranial tumours. Cancer 37:1869–1873Google Scholar
  6. 6.
    Brooks WH, Markesbery WR, Gupta GD, Roszman TL (1978) Relationship of lymphocyte invasion and survival of brain tumour patients. Ann Neurol 4:219–224Google Scholar
  7. 7.
    Bullard DE, Bigner DD (1985) Applications of monoclonal antibodies in the diagnosis and treatment of primary brain tumours. J Neurosurg 63:2–16Google Scholar
  8. 8.
    Bullard DE, Gillespie GY, Mahaley MS, Bigner D (1986) Immunobiology of human gliomas. Semin Oncol 13:94–104Google Scholar
  9. 9.
    Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumours. Proc Natl Acad Sci USA 72:3666–3671Google Scholar
  10. 10.
    Cordingley FT, Hoffbrand AV, Heslop HE, Turner M, Bianchi A, Reittie JE, Vyakarnam A, Meager A (1988) Tumour necrosis factor as an autocrine tumour growth factor for chronic B cell malignancies. Lancet I:969–971Google Scholar
  11. 11.
    Davey SR, Cordell JR, Erber WN, Pulford KAI, Gatter KC, Mason DY (1988) A monoclonal antibody (Y182A) with specificity towards peripheral blood monocytes and tissue macrophages. J Clin Pathol 41:753–758Google Scholar
  12. 12.
    Elliott LH, Brooks WH, Roszman TL (1984) Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumours. J Immunol 132:1208–1215Google Scholar
  13. 13.
    Elliott LH, Brooks WH, Roszman TL (1987) Activation of immunoregulatory lymphocytes obtained from patients with malignant gliomas. J Neurosurg 67:231–236Google Scholar
  14. 14.
    Fontana A, Hengartner H, de Tribolet N, Weber E (1984) Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J Immunol 132: 1837–1844Google Scholar
  15. 15.
    Hitchcock ER, Morris CS (1988) Mononuclear cell infiltration in central portions of human astrocytomas. J Neurosurg 68:432–437Google Scholar
  16. 16.
    Kehrl JH, Miller A, Fauci AS (1987) Effects of TNF alpha on mitogen-activated human B cells. J Exp Med 166:786–791Google Scholar
  17. 17.
    Kernohan JW, Mabon RF, Stein JH, Adson AW (1949) A simplified classification of the gliomas. Proc Staff Meet Mayo Clin 24:71–75Google Scholar
  18. 18.
    Kril MP, Apuzzo MLJ (1983) Observations in the study of T lymphocyte subsets by monoclonal antibodies and flow cytometric analysis in intracranial neoplastic disorders. Clin Neurosurg 30:125–136Google Scholar
  19. 19.
    Lee E, Desu M (1972) A computer program for comparing k samples with right-censored data. Comput Programs Biomed 2:315–321Google Scholar
  20. 20.
    Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N (1987) Macrophage-induced angiogenesis mediated by tumour necrosis factor-alpha. Nature 329:630–632Google Scholar
  21. 21.
    Mahaley MS, Brooks WH, Roszman TL, Bigner DD, Dudka L, Richardson S (1977) Immunobiology of primary intracranial tumours. Part 1: Studies of the cellular and humoral general immune competence of brain tumour patients. J Neurosurg 46:467–476Google Scholar
  22. 22.
    Morantz RA, Wood GW, Foster M, Clark M, Gollahon K (1979) Macrophages in experimental and human tumours. Part 2: Studies of the macrophage content of human brain tumours. J Neurosurg 50:305–311Google Scholar
  23. 23.
    Mork SJ, Nyland H, Matre R, Ganz J (1985) Characterization of host mononuclear cells in gliomas. J Neuropathol Exp Neurol [Abstr] 44:317Google Scholar
  24. 24.
    Palma L, Di Lorenzo N, Guidetti B (1978) Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas: incidence, fate and relevance to prognosis in 228 operated cases. J Neurosurg 49:854–861Google Scholar
  25. 25.
    Rainbird S, Alwood G, Ridley A (1981) Lymphocyte-mediated cytotoxicity against gliomas. Brain 104:451–464Google Scholar
  26. 26.
    Ridley A, Cavanagh JB (1971) Lymphocytic infiltration in gliomas: evidence of possible host resistance. Brian 94: 117–124Google Scholar
  27. 27.
    Rossi ML, Hughes JT, Esiri MM, Coakham HB, Brownell DB (1987) Immunohistological study of mononuclear cell infiltrate in malignant gliomas. Acta Neuropathol (Berl) 74:269–277Google Scholar
  28. 28.
    Rossi ML, Cruz-Sanchez FF, Hughes JT, Esiri MM, Coakham HB, Moss TH (1988) Mononuclear cell infiltrate and HLA-DR expression in low-grade astrocytomas: an immunohistological study of 23 cases. Acta Neuropathol 76:281–286Google Scholar
  29. 29.
    Rossi ML, Esiri MM, Cruz-Sanchez FF, Hughes JT, Coakham HB, Moss TH (1989) Characterization of the mononuclear cell infiltrate in 14 oligodendrogliomas: an immunohistological study. Br J Neurosurg (in press)Google Scholar
  30. 30.
    Schiffer D, Croveri G, Pautasso C (1974) Frequenza e significato degli infiltrati linfo-plasmacellulari nei gliomi umani. Tumori 60:177–184Google Scholar
  31. 31.
    Stavrou D, Anzil AP, Weidenbach W, Rodt H (1977) Immunofluorescence study of lymphocytic infiltration in gliomas. Identification of T lymphocytes. J Neurol Sci 33:275–282Google Scholar
  32. 32.
    Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA Jr, Shepard HM (1986) Recombinant human tumour necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science 230:943–945Google Scholar
  33. 33.
    Takeuchi J, Barnard RO (1976) Perivascular lymphocytic cuffing in astrocytomas. Acta Neuropathol (Berl) 35:265–271Google Scholar
  34. 34.
    Vilcek J, Palombella VJ, Henriksen-De Stefano D, Swenson C, Feinmman R, Hirai M, Tsujimoto M (1986) Fibroblast growth enhancing activity of TNF and its relationship to other polypeptide growth factors. J Exp Med 163:632–644Google Scholar
  35. 35.
    Von Hanwehr RI, Hofman FM, Taylor CR, Apuzzo MLJ (1984) Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumours. Characterization of cell subsets with monoclonal antibodies. J Neurosurg 60:1138–1147Google Scholar
  36. 36.
    Vose BM, Moore M (1985) Human tumour-infiltrating lymphocytes: a marker of host response. Semin Hematol 22:27–40Google Scholar
  37. 37.
    Williamson BD, Carswell EA, Rubin BY (1983) Human TNF produced by human B cell lines: synergistic cytotoxic interaction with human IF. Proc Natl Acad Sci USA 80:5397–5401Google Scholar
  38. 38.
    Zucali JR, Elfenbein GJ, Barth KC, Dinarello CA (1987) Effects of human IL 1 and human TNF on human T lymphocyte colony formation. J Clin Invest 80:772–777Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • M. I. Rossi
    • 1
  • N. R. Jones
    • 1
  • E. Candy
    • 3
  • J. A. R. Nicoll
    • 4
  • J. S. Compton
    • 2
  • J. T. Hughes
    • 1
  • M. M. Esiri
    • 1
  • T. H. Moss
    • 4
  • F. F. Cruz-Sanchez
    • 1
  • H. B. Coakham
    • 3
  1. 1.Department of NeuropathologyRadcliffe InfirmaryOxfordUK
  2. 2.Department of NeurosurgeryRadcliffe InfirmaryOxfordUK
  3. 3.Department of NeurosurgeryFrenchay HospitalBristolUK
  4. 4.Department of NeuropathologyFrenchay HospitalBristolUK

Personalised recommendations